Abrupt FDA ex­its spark con­cern; Un­pack­ing key con­cepts at gene ther­a­py sum­mit; 20 lu­mi­nar­ies who re­shaped R&D; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

As Twit­ter folks would say, what a month this past week has been! I’d rec­om­mend go­ing through this re­port care­ful­ly to find the big news that prob­a­bly got buried un­der even big­ger news. For those of you who sub­scribe to our dai­ly newslet­ters, we will be off on Mon­day in ob­ser­vance of La­bor Day in the US and will be back on Mon­day. I’m ready to take in the long week­end — and hope yours is just what you need it to be.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER